- Report
- May 2023
- 147 Pages
Global
From €4418EUR$4,949USD£3,865GBP
- Report
- May 2023
- 147 Pages
Global
From €4418EUR$4,949USD£3,865GBP
- Report
- January 2024
- 170 Pages
Global
€4459EUR$4,995USD£3,901GBP
- Report
- June 2024
- 112 Pages
Global
From €13387EUR$14,995USD£11,712GBP
- Report
- February 2020
- 173 Pages
Global
From €13387EUR$14,995USD£11,712GBP
- Report
- April 2024
- 81 Pages
Africa, Middle East
From €2634EUR$2,950USD£2,304GBP
- Report
- April 2024
- 81 Pages
From €2634EUR$2,950USD£2,304GBP
- Report
- April 2024
- 97 Pages
Asia Pacific
From €2634EUR$2,950USD£2,304GBP
- Report
- April 2024
- 100 Pages
Europe
From €2634EUR$2,950USD£2,304GBP
- Report
- April 2024
- 90 Pages
North America
From €3080EUR$3,450USD£2,695GBP
- Report
- April 2024
- 105 Pages
Global
From €3080EUR$3,450USD£2,695GBP
- Report
- April 2024
- 192 Pages
Global
From €4419EUR$4,950USD£3,866GBP
- Report
- May 2021
- 97 Pages
Global
€19640EUR$22,000USD£17,183GBP
- Report
- August 2024
- 272 Pages
China
From €3571EUR$4,000USD£3,124GBP
- Report
- May 2022
- 47 Pages
Global
From €1785EUR$2,000USD£1,562GBP
- Report
- May 2022
- 84 Pages
Global
From €1785EUR$2,000USD£1,562GBP
- Report
- October 2024
- 70 Pages
Global
From €3500EUR$4,200USD£3,169GBP
- Report
- September 2024
- 81 Pages
Global
From €3500EUR$4,200USD£3,169GBP
- Report
- May 2023
- 98 Pages
Global
From €3500EUR$4,200USD£3,169GBP
- Report
- February 2024
- 111 Pages
Global
From €3500EUR$4,200USD£3,169GBP

Progesterone is a hormone that plays an important role in women's health. It is produced by the ovaries and is essential for the regulation of the menstrual cycle, fertility, and pregnancy. Progesterone is also used to treat a variety of conditions, including abnormal uterine bleeding, endometriosis, and premenstrual syndrome. It is available in a variety of forms, including oral tablets, topical creams, and injections.
The progesterone market is an important part of the women's health industry. It is driven by the increasing prevalence of conditions such as endometriosis and premenstrual syndrome, as well as the growing demand for hormone replacement therapy. The market is also influenced by the availability of new products and technologies, such as transdermal patches and vaginal rings.
Some companies in the progesterone market include Pfizer, Merck, AbbVie, and Novo Nordisk. Show Less Read more